P. Kovoor et al., RADIATION EXPOSURE TO PATIENT AND OPERATOR DURING RADIOFREQUENCY ABLATION FOR SUPRAVENTRICULAR TACHYCARDIA, Australian and New Zealand Journal of Medicine, 25(5), 1995, pp. 490-495
Aim: To quantitate radiation exposure to patient and operator during R
F ablation for supraventricular tachycardia. Methods: Thermoluminescen
t dosemeters were used to monitor radiation at seven sites. Positions
were: patient's thyroid, left scapula, T9 vertebra, right scapula and
L4-L5 vertebra and the operator's thyroid and left hand. Monitoring wa
s performed during 22 procedures. Of the patients studied 10 (45%) had
atrioventricular junctional re-entry tachycardia (AVJRT) and 12 (55%)
had accessory pathway tachycardia. Results: The median fluoroscopy ti
mes (minutes) and inter-quartile ranges were 46 (39-65) for AVJRT, 55
(52-60) for left free wall accessory pathway(LFW), 107 (89-140) for se
ptal and 166 (128-176) for RFW pathways. The mean radiation doses (mGy
) to the chest wall were 50 for AVJRT, 47 for LFW, 87 for septal and 1
51 for RFW pathways. The mean radiation to the chest wall of the patie
nt per case was found to be 3.9 times that reported for diagnostic car
diac catheterisation and 1.5 times that reported for angioplasty. Conc
lusions: Radiofrequency ablation is associated with significant irradi
ation of the patient and operator. All precautions should be taken to
decrease this exposure. If eye irradiation is assumed to be equal to t
hat to the thyroid more than 45 procedures per month by a single opera
tor (using ceiling-suspended lead glass shielding) may result in excee
ding the recommended dose limit to the eye.